Alternatives to Graph Therapeutics
Graph Therapeutics is a Biotechnology tool: developing precision medicines for inflammatory and immune-mediated diseases using AI and patient sample analysis. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Graph Therapeutics profileOpen source alternatives (5)More Biotechnology alternatives
The 20 closest Biotechnology companies to Graph Therapeutics
- Website SISightera Biosciences43BiotechnologyAntwerp, Belgium$3.0M
AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.
- EXExscientia2HealthcareOxford, United Kingdom
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
Freenome59BiotechnologySouth San Francisco, USA$570.0MFreenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
- Website
Pixelgen Technologies62BiotechnologyStockholm, Sweden$43.5MA life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.
- Website SPSpliceBio54BiotechnologyCambridge, United States$100.0M
Biotechnology company developing next-generation gene therapies using a proprietary protein splicing platform.
- Website KHKhartis Therapeutics, Inc.53BiotechnologySan Diego, United States$50.0M
Developing oral small molecule medicines for immunological and chronic diseases.
- Website
Immix Biopharma, Inc.51BiotechnologyLos Angeles, United States$5.0MA clinical-stage biopharmaceutical company developing novel cell therapies for AL Amyloidosis and other serious diseases.
- Website
Meta-Flux50BiotechnologyDublin, Ireland$101.9MAI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.
- Website
Immitra Bio48BiotechnologyZürich, Switzerland$2.6MScalable, one-time curative in-vivo gene editing therapies.
- Website
IMU Biosciences47BiotechnologyLondon, United Kingdom$53.0MDecoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.
- Website TOTolemy Bio46BiotechnologyCambridge, United Kingdom$1.4M
AI-enabled technology for cell biology research and biopharma development.
- Website
Houdini Bio42BiotechnologyCambridge, United Kingdom$1.7MEngineering-driven DNA design platform to overcome biological barriers in genetic medicines.
- Website
Virchow Medical41BiotechnologyLa Jolla, USA$4.0MAdvancing biopsy specimen stewardship and expanding access to precision oncology.
- Website
InduPro, Inc.39BiotechnologySeattle, United States$77.0MBiotechnology company defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website AVAvant Genomics34BiotechnologyCharlottesville, USA$3.0M
Developing an automated platform for liquid biopsy sample preparation.
- Website
BioNTech66BiotechnologyMainz, Germany$975.0MGlobal biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.
- Website
Mammoth Biosciences63BiotechnologyBrisbane, United States$460.0MBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Showing the 20 closest matches. See the rest on the Graph Therapeutics profile.
Compare Graph Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.